Natalia París (@Parissotes) profile picture

Pharma marketing #soyPromociona

Barcelona, España
Joined February 2013
Photo by Natalia París (@Parissotes)Photo by Natalia París (@Parissotes)Photo by Natalia París (@Parissotes)Photo by Natalia París (@Parissotes)Photo by Natalia París (@Parissotes)Photo by Natalia París (@Parissotes)Photo by Natalia París (@Parissotes)Photo by Natalia París (@Parissotes)Photo by Natalia París (@Parissotes)Photo by Natalia París (@Parissotes)
Natalia París retweeted
Imagínate un trombo en tu cerebro... sufriremos #Ictus isquémico... Emergencias SUMMA 112... Código Ictus... Hospital... Equipo médico neurorradiología intervencionista... y tecnología cardiovascular @iVascularGlobal @CARDIVAGROUP Mañana, muy buenas noticias para tod@s nosotr@s
5
7
Natalia París retweeted
Today, on #worldstrokeday, we are pleased to announce the expansion of our treatment areas with the neurovascular pipeline. This portfolio has been designed to provide new tools that can help in the treatment of ischemic stroke patients. #ischemicstroke #iVascular #neuro
3
5
Natalia París retweeted
Replying to @CXSymposium
Great iliac case from Bad Krozingen : the first ILICO enrollment!!! @iVascularGlobal
1
3
Natalia París retweeted
When you choose us, you choose the knowledge of the best professionals. Means are important, but it is the people behind it who make it possible > bit.ly/Angiolite-ENG #iVascular #westandbyyou #westentbyyou #TheDESwetrust #DES
Natalia París retweeted
At iVascular, we believe in gender equality for a sustainable tomorrow. Today, we have asked our women directors to share a thought on #InternationalWomensDay2022 #BreakTheBias
3
5
Natalia París retweeted
Have you ever wondered who belongs to the team behind Angiolite's development? Let us share it with you. Stay tuned. Soon we'll stand by you #iVascular #westandbyyou
Natalia París retweeted
Today on the #InternationalDayOfWomenandGirlsinscience, we want to put a spotlight on our women in science. Their work and dedication as part of iVascular’s R&D team, allow us to keep innovating in medical technology and fulfill our purpose of bringing value to society.
1
2
1
7
Natalia París retweeted
Running the @IcohOrg @ICOH2022 , Barcelona ICOH 2027 GO! VOTE!
3
28
2
26
Natalia París retweeted
In line with our commitment to cardiovascular health, through sports. We are proud to support the 2021 Women's World Championship, this year in Spain. Follow the championship here: @SheLOVsHandball #iVascular #SheLovesHandball
NOW con Helena Legido-Quigley From Shangai to Sitges Aprendiendo sobre Salud Global en nuestro III Summit Salud&Farma @AsocEyC @OrriolsRosa @belen_torrijos @patriciaafdez @sabrinafemenia @MiriamRodrAspem @MGG_2012 @Estrell67715016 @Parissotes @XtinaBescos @nitidapastor
8
14
Un honor compartir experiencias con mujeres maravillosas ocupando cargos de liderazgo en Salud. Una inspiración! @AsocEyC @patriciaafdez @belen_torrijos @OrriolsRosa @FXavierGarciaO @MiriamRodrAspem @Estrell67715016 @XtinaBescos @martaantonb @NereaTorresE @sabrinafemenia @1971Pe
2
21
9
52
Natalia París retweeted
Another proof of Paclitaxel safety and efficacy... in all circumstances... around the world....🤛 @iVascularGlobal @VascularNews @EVToday #paclitaxel
This Post is from a suspended account. Learn more
3
3
Natalia París retweeted
Read more about MERLION Trial outcomes at @EVToday . MERLION results prove that luminor DCB is safe and efficacious in treating highly complex infra-popliteal atherosclerotic lesions, in challenging CLTI patients. #endovascular #clinicaltrials #DCB bit.ly/2Bu6Tq1
3
4
Natalia París retweeted
MERLION trial 6-month outcomes were revealed yesterday, at VIVA 2020 Late-breaking trial session. Dr. Tang concluded that “luminor DCB is safe and efficacious, in treating highly complex infra-popliteal atherosclerotic lesions” Read more at cutt.ly/Fib4Tfr.
Natalia París retweeted
We are pleased to announce essential pro, our new coronary DCB. essential pro has an optimal navigation, thanks to its new optimized platform, which allows it to reach the most complex and distal lesions. To learn more about essential pro visit: cutt.ly/IuvQ6Gb #DCB
3
7
Thanks to #DIRCOM for their strategic and hard work in the heat of #COVID19 pandemic and their collaboration with @CataloniaBioHT: @Jordi_Roy @marccostap @olcajal @MauriciTorner @Parissotes @guidiazale @Esclarmund, among others without Twitter 😉 #corporatecommunications
📸 PHOTOS | How do @CataloniaBioHT companies work in the heat of the #COVID19 pandemic? Security, effort and commitment to ensure hospitals and chemists have a steady supply of essential products and medicines ow.ly/hIq130qyxiE
Natalia París retweeted
Due to the spread of COVID 19, video conferences are becoming more routine. Making these virtual meetings efficient, is key to achieve our objectives. Harvard Business Review (cutt.ly/xt3pghl) shares a few tips on how to achieve it. #iVascular #COVID19
3
6
Natalia París retweeted
At iVascular we are taking several measures to ensure the support towards our workforce during these challenging times. Harvard Business Review (bit.ly/2xZFXMQ) states that open communication within the company is key to reduce uncertainty. #iVascular #COVID19
3
4
Natalia París retweeted
Our workforce sends support messages to all of the people working during this COVID-19 pandemic. Maintaining a positive mindset and following all the safety guidelines are key to preserve not only our physical but also our psychological health. youtu.be/YZVtXNY5qg0
3
7
Natalia París retweeted
In the last session of iVS, the main debate has been BTK treatment. The speakers agreed that sometimes PTA balloons are not enough, and the use of DCBs, DES or atherectomy can be a good option. Nevertheless, they concluded that more scientific data is needed. #iVS #iVascular
2
4